Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹32 Cr
Revenue (TTM)
₹55 Cr
Net Profit (TTM)
₹-1 Cr
ROE
-4.9 %
ROCE
5.1 %
P/E Ratio
--
P/B Ratio
1.1
Industry P/E
41.94
EV/EBITDA
6.6
Div. Yield
0 %
Debt to Equity
0.4
Book Value
₹79.7
EPS
₹-3
Face value
10
Shares outstanding
3,648,300
CFO
₹35.18 Cr
EBITDA
₹50.76 Cr
Net Profit
₹10.28 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Centenial Surgical
| -15.4 | -13.0 | -16.3 | -3.3 | 15.4 | 10.3 | 2.4 |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Centenial Surgical
| -24.4 | 39.3 | 75.0 | 3.4 | 10.5 | 50.1 | -53.3 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Centenial Surgical
|
87.0 | 31.7 | 54.6 | -1.1 | 3.6 | -3.5 | -- | 1.1 |
| 64.5 | 32.5 | 150.3 | -2.2 | -0.6 | -4.8 | -- | 0.6 | |
| 1,664.8 | 27,406.4 | 6,112.8 | 847.2 | 17.2 | 9.2 | 32.4 | 2.8 | |
| 177.0 | 972.3 | 264.6 | 19.3 | 8.9 | 6.2 | 41.9 | 4.2 | |
| 845.4 | 10,147.0 | 6,537.7 | 207.0 | 4.6 | 11.5 | 49 | 5.3 | |
| 17.5 | 9.6 | 7.3 | 0.6 | 10.6 | 47.6 | 16.4 | 6.1 | |
| 1,279.1 | 12,965.9 | 1,781.6 | 341.3 | 19.8 | 12.4 | 37.3 | 4.3 | |
| 116.4 | 42.8 | 20.6 | 2.5 | 18.7 | 16.9 | 17.2 | 2.6 |
No Review & Analysis are available.
Manufacture of bone plates and screws, syringes, needles, catheters, cannulae, etc.
Incorporated
1995
Chairman
--
Managing Director
Vijay Majrekar
Headquarters
Thane, Maharashtra
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Centenial Surgical Suture Ltd is ₹87.00 (BSE) as of 18-Mar-2026 IST. Centenial Surgical Suture Ltd has given a return of 15.37% in the last 3 years.
Since, TTM earnings of Centenial Surgical Suture Ltd is negative, P/E ratio is not available.
The P/B ratio of Centenial Surgical Suture Ltd is 1.09 times as on 18-Mar-2026, a 61 discount to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.38
|
|
2024
|
29.38
|
1.09
|
|
2023
|
25.40
|
0.77
|
|
2022
|
35.34
|
0.78
|
|
2021
|
16.22
|
0.56
|
The 52-week high and low of Centenial Surgical Suture Ltd are Rs 189.00 and Rs 82.15 as of 19-Mar-2026.
Centenial Surgical Suture Ltd has a market capitalisation of ₹ 32 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Centenial Surgical Suture Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-1.47
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.